Physician profile
Ali Nsair
NPI 1366739880
$162,284.07
in general payments reported to CMS, 2019-2025
18 companies · $663 in 2025
The $663 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $9,378 · 2021: $9,326 · 2022: $32K · 2023: $22K · 2024: $24K · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $5,556 · Food and Beverage: $1,517 · Consulting Fee: $900 · Education: $6.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,872.00 |
| Travel and Lodging | $5,555.91 |
| Food and Beverage | $1,516.90 |
| Consulting Fee | $900.00 |
| Education | $6.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $65,344.57 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $44,976.52 | 2022-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $27,302.44 | 2020-2023 | Farxiga |
| Philips North America LLC | $17,677.74 | 2022 | |
| Abbott Laboratories | $3,740.29 | 2019-2021 | |
| Abiomed | $803.76 | 2019-2020 | |
| Cardiovascular Systems INC. | $730.56 | 2019 | |
| Heartflow, INC. | $282.54 | 2025 | |
| Boston Scientific Corporation | $265.55 | 2019-2025 | Emerge Push |
| Cvrx, INC. | $265.49 | 2022 | |
| Medtronic Vascular, INC. | $192.23 | 2019 | |
| Shockwave Medical, INC | $173.28 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.55 | 2019-2025 | Lifevest |
| Penumbra, INC. | $149.00 | 2022 | |
| Endotronix, INC. | $142.25 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $37.30 | 2020 | |
| Nuwellis, INC. | $30.00 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Nsair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.